Skip to content

An interventional study to evaluate the safety and performance of bovine pericardial tissue patch use in Peyronie’s disease.

Assessing outcomes following penile corrective surgeries using bovine pericardial patch: A prospective cohort study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070277
Enrollment
15
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N52- Male erectile dysfunction

Interventions

Intervention1: Bovine Pericardial Tissue Patch: Tisgenx’s BPT Patch is intended for use as a surgical patch for cardiac and vascular reconstruction and repair, soft tissue deficiency repair, and reinf

Sponsors

Tisgenx, Inc.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with disabling penile curvature 2. Tunical plaques in patients with Peyronie’s disease 3. Willingness to participate and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Patients requiring prostheses 2. Congenital penile curvature 3. Patients with constriction bands, unilateral indentations, and hourglass deformities 4. Patients with known allergies to bovine products or pre-existing conditions contraindicating the use of bovine pericardial patches.

Design outcomes

Primary

MeasureTime frame
• Safety: Incidence of adverse events related to the use of bovine pericardial patch, including infections, thrombosis, and allergic reactions. • Efficacy: Patency rates of the grafts assessed through clinical photos of erection at specified follow-up intervals.Timepoint: The study will follow up with patients for a minimum of 1 month postoperatively to evaluate short-term outcomes. Long-term outcomes will also be assessed during subsequent follow-up periods, 3 months, 6 months and 1 year.

Secondary

MeasureTime frame
• Patients will be examined post-surgery by evaluating the ability to perform successful sexual intercourse, improvements in curvature, and satisfaction with treatment • Patch handling and characteristicsTimepoint: The study will follow up with patients for a minimum of 1 month postoperatively to evaluate short-term outcomes. Long-term outcomes will also be assessed during subsequent follow-up periods, 3 months, 6 months and 1 year.

Countries

India

Contacts

Public ContactDr Pankaj Joshi

Urokul Hospital

drpankajmjoshi@gmail.com9923406464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026